Caplin Point Laboratories (CAPLIPOINT.NS) Stock Price

Caplin Point Laboratories Price

NSE·CLOSED
2,616.10INR+32.50 (+1.25 %)
Market closed

Revenue has compounded at 24.4% per year over the past 18 years to 19.37 B INR. Earnings per share have grown at 37.9% per year over the last 18 years. Caplin Point Laboratories's net margin stands at 27.7%, up from 22.8% several years earlier. Caplin Point Laboratories currently offers a dividend yield of about 0.23%. The payout ratio is around 9% of earnings. The dividend has grown at 3.8% per year over the past 11 years. Analysts set a median price target of 2,198.10 INR, implying 16.0% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 74% above its 52-week low.

Caplin Point Laboratories stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Caplin Point Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Caplin Point Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Caplin Point Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Caplin Point Laboratories Stock Price History
DateCaplin Point Laboratories Price
7/13/20262,616.10 INR
7/10/20262,583.60 INR
7/9/20262,621.40 INR
7/8/20262,528.40 INR
7/7/20262,566.80 INR
7/6/20262,624.20 INR
7/3/20262,532.50 INR
7/2/20262,538.20 INR
7/1/20262,564.00 INR
6/30/20262,626.00 INR
6/29/20262,557.90 INR
6/25/20262,506.40 INR
6/24/20262,519.00 INR
6/23/20262,490.90 INR
6/22/20262,537.40 INR
6/19/20262,381.90 INR
6/18/20262,362.00 INR
6/17/20262,388.20 INR
6/16/20262,382.80 INR
6/15/20262,372.10 INR
6/12/20262,355.50 INR
6/11/20262,352.60 INR
6/10/20262,306.30 INR
6/9/20262,255.20 INR
6/8/20262,111.00 INR
6/5/20262,022.00 INR
6/4/20262,019.70 INR
6/3/20261,972.90 INR
6/2/20261,988.10 INR
6/1/20262,054.30 INR
5/29/20262,044.10 INR
5/27/20262,050.20 INR
5/26/20262,084.50 INR
5/25/20262,058.30 INR
5/22/20262,030.30 INR
5/21/20262,046.60 INR
5/20/20262,026.50 INR
5/19/20262,038.20 INR
5/18/20261,986.10 INR
5/15/20261,998.80 INR
5/14/20262,023.80 INR
5/13/20261,841.80 INR
5/12/20261,815.00 INR
5/11/20261,853.30 INR
5/8/20261,856.30 INR
5/7/20261,866.60 INR
5/6/20261,841.30 INR
5/5/20261,741.50 INR
5/4/20261,736.30 INR
4/30/20261,709.00 INR
4/29/20261,727.60 INR
4/28/20261,732.20 INR
4/27/20261,761.10 INR
4/24/20261,719.50 INR
4/23/20261,768.00 INR
4/22/20261,752.50 INR
4/21/20261,748.80 INR
4/20/20261,754.20 INR
4/17/20261,770.90 INR
4/16/20261,764.90 INR
4/15/20261,735.60 INR
4/13/20261,687.10 INR
4/10/20261,708.40 INR
4/9/20261,662.00 INR
4/8/20261,660.30 INR
4/7/20261,610.50 INR
4/6/20261,569.10 INR
4/2/20261,565.80 INR
4/1/20261,570.10 INR
3/30/20261,504.80 INR
3/27/20261,558.40 INR
3/25/20261,595.00 INR
3/24/20261,594.00 INR
3/23/20261,563.50 INR
3/20/20261,609.90 INR
3/19/20261,622.00 INR
3/18/20261,641.00 INR
3/17/20261,634.80 INR
3/16/20261,632.00 INR
3/13/20261,659.70 INR
3/12/20261,684.80 INR
3/11/20261,685.00 INR
3/10/20261,690.00 INR
3/9/20261,669.20 INR
3/6/20261,665.00 INR
3/5/20261,653.30 INR
2/27/20261,700.10 INR
2/26/20261,721.30 INR
2/25/20261,729.00 INR
2/24/20261,713.80 INR
2/23/20261,739.00 INR
2/20/20261,692.10 INR
2/19/20261,699.80 INR
2/18/20261,707.20 INR
2/17/20261,722.30 INR
2/16/20261,717.90 INR
2/13/20261,731.20 INR
2/12/20261,731.00 INR
2/11/20261,746.70 INR
2/10/20261,734.00 INR
2/9/20261,761.70 INR
2/6/20261,834.00 INR
2/5/20261,900.00 INR
2/4/20261,909.50 INR
2/3/20261,889.20 INR
2/2/20261,798.00 INR
1/30/20261,773.90 INR
1/29/20261,720.00 INR
1/28/20261,753.80 INR
1/27/20261,730.10 INR
1/23/20261,748.60 INR
1/22/20261,734.00 INR
1/21/20261,721.00 INR
1/20/20261,777.00 INR
1/19/20261,815.00 INR
1/16/20261,821.00 INR
1/14/20261,845.00 INR
1/13/20261,806.20 INR
1/12/20261,803.40 INR
1/9/20261,819.00 INR
1/8/20261,818.90 INR
1/7/20261,854.80 INR
1/6/20261,838.30 INR
1/5/20261,845.30 INR
1/2/20261,848.00 INR
1/1/20261,808.00 INR
12/31/20251,838.10 INR
12/30/20251,797.00 INR
12/29/20251,889.20 INR
12/26/20251,915.80 INR
12/24/20251,965.10 INR
12/23/20251,979.00 INR
12/22/20251,953.80 INR
12/19/20251,930.00 INR
12/18/20251,915.00 INR
12/17/20251,897.80 INR
12/16/20251,945.00 INR
12/15/20251,956.20 INR
12/12/20251,958.00 INR
12/11/20251,954.00 INR
12/10/20251,928.20 INR
12/9/20251,904.80 INR
12/8/20251,927.60 INR
12/5/20251,958.00 INR
12/4/20251,980.00 INR
12/3/20251,888.00 INR
12/2/20251,912.00 INR
12/1/20251,909.10 INR
11/28/20251,905.50 INR
11/27/20251,916.00 INR
11/26/20251,920.00 INR
11/25/20251,905.90 INR
11/24/20251,915.00 INR
11/21/20251,911.10 INR
11/20/20251,917.80 INR
11/19/20251,934.00 INR
11/18/20251,910.90 INR
11/17/20251,943.20 INR
11/14/20251,921.90 INR
11/13/20251,930.10 INR
11/12/20251,949.10 INR
11/11/20251,942.00 INR
11/10/20251,943.20 INR
11/7/20251,932.50 INR
11/6/20252,007.70 INR
11/4/20251,992.80 INR
11/3/20252,006.20 INR
10/31/20252,028.00 INR
10/30/20252,032.90 INR
10/29/20252,025.00 INR
10/28/20252,013.00 INR
10/27/20252,016.10 INR
10/24/20251,993.10 INR
10/23/20252,024.90 INR
10/21/20252,029.90 INR
10/20/20252,012.00 INR
10/17/20251,988.00 INR
10/16/20252,014.00 INR
10/15/20252,024.00 INR
10/14/20251,973.10 INR
10/13/20252,013.00 INR
10/10/20252,051.90 INR
10/9/20252,026.10 INR
10/8/20251,998.20 INR
10/7/20251,997.00 INR
10/6/20252,020.10 INR
10/3/20252,031.00 INR
10/1/20252,058.50 INR
9/30/20251,972.00 INR
9/29/20252,010.20 INR
9/26/20252,036.90 INR
9/25/20252,183.60 INR
9/24/20252,250.10 INR
9/23/20252,254.00 INR
9/22/20252,307.10 INR
9/19/20252,318.00 INR
9/18/20252,322.00 INR
9/17/20252,328.00 INR
9/16/20252,248.00 INR
9/15/20252,275.00 INR
9/12/20252,243.30 INR
9/11/20252,226.20 INR
9/10/20252,214.40 INR
9/9/20252,203.90 INR
9/8/20252,175.00 INR
9/5/20252,130.10 INR
9/4/20252,115.00 INR
9/3/20252,161.00 INR
9/2/20252,127.40 INR
9/1/20252,102.00 INR
8/29/20252,095.90 INR
8/28/20252,145.00 INR
8/26/20252,079.50 INR
8/25/20252,162.20 INR
8/22/20252,187.50 INR
8/21/20252,211.10 INR
8/20/20252,122.70 INR
8/19/20252,136.30 INR
8/18/20252,152.00 INR
8/14/20252,132.00 INR
8/13/20252,160.00 INR
8/12/20252,099.90 INR
8/11/20252,105.00 INR
8/8/20252,111.00 INR
8/7/20252,058.30 INR
8/6/20251,934.30 INR
8/5/20251,960.00 INR
8/4/20252,008.60 INR
8/1/20251,988.10 INR
7/31/20252,066.40 INR
7/30/20252,145.80 INR
7/29/20252,088.00 INR
7/28/20252,051.30 INR
7/25/20252,036.90 INR
7/24/20252,091.00 INR
7/23/20252,109.10 INR
7/22/20252,080.00 INR
7/21/20252,100.00 INR
7/18/20252,105.00 INR
7/17/20252,109.50 INR
7/16/20252,079.30 INR
Access this data via the Eulerpool API
Get Free API Key

Caplin Point Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
10.61 B INR
2.92 B INR
2.42 B INR
Jan 1, 2022
12.69 B INR
3.48 B INR
3.00 B INR
Jan 1, 2023
14.67 B INR
3.97 B INR
3.76 B INR
Jan 1, 2024
16.94 B INR
4.99 B INR
4.57 B INR
Jan 1, 2025
19.37 B INR
5.85 B INR
5.36 B INR
Jan 1, 2026 (e)
22.02 B INR
14.92 B INR
6.39 B INR
Jan 1, 2027 (e)
24.57 B INR
16.46 B INR
7.04 B INR
Jan 1, 2028 (e)
26.88 B INR
18.40 B INR
7.72 B INR

Caplin Point Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 15, 2026, 5:59 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
1.271.732.522.394.025.406.498.6310.6112.6914.6716.9419.3722.0224.5726.88
18.4736.3045.47-5.2068.2434.4120.1733.0722.9519.6115.5415.5014.3613.6511.579.41
31.6536.8039.7543.5750.8053.5853.0950.0353.6954.1752.6354.9657.8957.8957.8957.89
0.400.641.001.042.042.893.444.325.706.887.729.3111.2212.7514.2215.56
0.140.260.410.460.961.451.772.152.423.003.764.575.366.397.047.72
75.0084.2958.9111.71108.7351.4621.9621.7412.7023.7325.4821.4817.3519.2110.109.65
–4.005.006.001.402.002.202.500.804.004.505.006.006.006.416.86
––25.0020.00-76.6742.8610.0013.64-68.00400.0012.5011.1120.00–6.837.02
76.0076.0076.0076.0076.0076.0076.0076.0076.0076.0076.5176.3176.3476.3476.3476.34
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Caplin Point Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Caplin Point Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Caplin Point Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Caplin Point Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Caplin Point Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Caplin Point Laboratories stock margins

The Caplin Point Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Caplin Point Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Caplin Point Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
53.69 %
27.54 %
22.83 %
Jan 1, 2022
54.17 %
27.42 %
23.62 %
Jan 1, 2023
52.63 %
27.05 %
25.65 %
Jan 1, 2024
54.97 %
29.45 %
26.98 %
Jan 1, 2025
57.89 %
30.19 %
27.68 %
Jan 1, 2026 (e)
57.89 %
67.76 %
29.04 %
Jan 1, 2027 (e)
57.89 %
67.02 %
28.66 %
Jan 1, 2028 (e)
57.89 %
68.45 %
28.72 %

Caplin Point Laboratories Stock Revenue, EBIT, Earnings per Share

The Caplin Point Laboratories earnings per share therefore indicates how much revenue Caplin Point Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
139.64 INR
38.46 INR
31.88 INR
Jan 1, 2022
167.03 INR
45.80 INR
39.45 INR
Jan 1, 2023
191.71 INR
51.86 INR
49.18 INR
Jan 1, 2024
222.00 INR
65.38 INR
59.90 INR
Jan 1, 2025
253.78 INR
76.62 INR
70.25 INR
Jan 1, 2026 (e)
289.67 INR
195.43 INR
84.12 INR
Jan 1, 2027 (e)
323.18 INR
215.66 INR
92.62 INR
Jan 1, 2028 (e)
353.60 INR
240.96 INR
101.54 INR

Caplin Point Laboratories business model & stock analysis

Caplin Point Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Caplin Point Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Caplin Point Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Caplin Point Laboratories shares outstanding

The number of shares of Caplin Point Laboratories was 76.34 M in 2025. This indicates how many shares Caplin Point Laboratories is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
76.00 M Stocks
Jan 1, 2022
76.00 M Stocks
Jan 1, 2023
76.51 M Stocks
Jan 1, 2024
76.31 M Stocks
Jan 1, 2025
76.34 M Stocks
Jan 1, 2026 (e)
76.34 M Stocks
Jan 1, 2027 (e)
76.34 M Stocks
Jan 1, 2028 (e)
76.34 M Stocks

Caplin Point Laboratories stock splits

In Caplin Point Laboratories's history, there have been no stock splits.

Caplin Point Laboratories Dividend History

12 years of dividend payments · 8 consecutive increases

YearAnnual DividendYoY ChangePayments
20256.00INR↑ 20.0%2×
May 30, 20253.00INR↑ 20.0%1/2
Sep 12, 20253.00INR 0.0%2/2
20245.00INR↑ 11.1%2×
20234.50INR↑ 12.5%2×
20224.00INR↑ 33.3%2×
20213.00INR↑ 20.0%2×
20202.50INR↑ 13.6%2×
20192.20INR↑ 10.0%1×
20182.00INR↑ 33.3%1×
20171.50INR↓ 75.0%1×
20166.00INR↑ 20.0%2×

Caplin Point Laboratories dividend history and estimates

In 2025, Caplin Point Laboratories paid a dividend amounting to 6.00 INR. Dividend means that Caplin Point Laboratories distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021 (e)
3.00 INR
-2.20 INR
Jan 1, 2022
4.00 INR
0.00 INR
Jan 1, 2023
4.50 INR
0.00 INR
Jan 1, 2024
5.00 INR
0.00 INR
Jan 1, 2025
6.00 INR
0.00 INR
Jan 1, 2026
6.00 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
6.41 INR
Jan 1, 2028 (e)
0.00 INR
6.86 INR

Caplin Point Laboratories dividend payout ratio

In 2025, Caplin Point Laboratories had a payout ratio of 8.54%. The payout ratio indicates the percentage of the company's profits that Caplin Point Laboratories distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
9.41 %
Jan 1, 2022
10.14 %
Jan 1, 2023
9.15 %
Jan 1, 2024
8.35 %
Jan 1, 2025
8.54 %
Jan 1, 2026 (e)
7.13 %
Jan 1, 2027 (e)
6.92 %
Jan 1, 2028 (e)
6.75 %

Current Caplin Point Laboratories forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
12.75 %
Buy85.71 % (6)
Hold14.29 % (1)
Sell0.00 % (0)
12M Price Target
2,198.10
Last Price
2,658.40
Currency
INR
12M Return Potential
-17.31 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Caplin Point Laboratories stock

63/100
22
Environment
92
Social
76
Governance
E

Environment

20
Scope 1 - Direct Emissions3,224
Scope 2 - Indirect emissions from purchased energy20,987
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions24,211
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees15.37
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Caplin Point Laboratories shareholder structure

% Name
24.70568%
Paarthipan (Vijayalakshmi)
Paarthipan (Vijayalakshmi)
18.63859%
Paarthipan (C C)
Paarthipan (C C)
11.90633%
Partheeban (Ashok Gorkey)
Partheeban (Ashok Gorkey)
11.85288%
Partheeban (Vivek Siddarth)
Partheeban (Vivek Siddarth)
3.10834%
Investor Education Protection Fund
Investor Education Protection Fund
2.78516%
May India Property Pvt. Ltd.
May India Property Pvt. Ltd.

Caplin Point Laboratories Executives and Management Board

SG

Dr. Sridhar Ganesan

(70)

Managing Director, Executive Director · since 2014

Compensation5.70 M INR
CP

Mr. Chingelput Paarthipan

(73)

Non-Executive Chairman of the Board

Compensation588,420.00 INR
SD

Mr. S. Deenadhayalan

(73)

Non-Executive Independent Director

Compensation550,000.00 INR
RN

Dr. R. Nagendran

Non-Executive Independent Director

Compensation225,000.00 INR
RV

Mr. Ranganathan Vijayaraghavan

(75)

Non-Executive Independent Director

Compensation150,000.00 INR

Frequently asked questions about Caplin Point Laboratories

Analysts currently set an average price target of 2,198.10 INR for the Caplin Point Laboratories stock (median: 2,198.10 INR), implying -17.3 % versus the latest price. The consensus is based on 7 analyst ratings.

Caplin Point Laboratories Analyst Price Targets 2026

All fundamentals and in-depth analysis of Caplin Point Laboratories

Our stock analysis for Caplin Point Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caplin Point Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Caplin Point Laboratories Stock
Caplin Point Laboratories Revenue→
Caplin Point Laboratories Stock
Caplin Point Laboratories Net Income→
Caplin Point Laboratories Stock
Caplin Point Laboratories P/E→
Caplin Point Laboratories Stock
Caplin Point Laboratories P/S→
Caplin Point Laboratories Stock
Caplin Point Laboratories EBIT→
Caplin Point Laboratories Stock
Caplin Point Laboratories Dividend→
Caplin Point Laboratories Stock
Caplin Point Laboratories Directors Dealings→
Caplin Point Laboratories Stock
Caplin Point Laboratories Stocks→
Caplin Point Laboratories Stock
Caplin Point Laboratories Market capitalization→
Caplin Point Laboratories Stock
Caplin Point Laboratories Debt→
Caplin Point Laboratories Stock
Caplin Point Laboratories Liabilities→
Caplin Point Laboratories Stock
Caplin Point Laboratories Equity→
Caplin Point Laboratories Stock
Caplin Point Laboratories AAQS→
Caplin Point Laboratories Stock
Caplin Point Laboratories Employees→
Caplin Point Laboratories Stock
Caplin Point Laboratories ROE→
Caplin Point Laboratories Stock
Caplin Point Laboratories ROA→
Caplin Point Laboratories Stock
Caplin Point Laboratories ROCE→
Caplin Point Laboratories Stock
Caplin Point Laboratories News→
Caplin Point Laboratories Stock
Caplin Point Laboratories Analyst Price Targets→

Health Stocks

Capricor TherapeuticsCantourage GroupCapsoVisionCanton Strategic HoldingsCapstone HoldingCantargiaCaptor CapitalCanSino BiologicsCardaxCanopy GrowthCardiff OncologyCannlabsAll Stocks A–Z →